Cargando…
Targeting the transcriptional activity of STAT3 by a novel fusion protein
BACKGROUND: The continuous activation of transcription factors drives many diseases, including tumors, autoimmune disease, neurodegenerative disease, and male infertility. Thus, Blocking the transcriptional activity of these proteins may inhibit disease progression. In this study, we developed a new...
Autores principales: | Chen, Yanqiong, Zhang, Wenting, Bai, Xiufeng, Liu, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271252/ https://www.ncbi.nlm.nih.gov/pubmed/35810312 http://dx.doi.org/10.1186/s12885-022-09837-1 |
Ejemplares similares
-
Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention
por: Xiong, Ailian, et al.
Publicado: (2014) -
Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain
por: Hua, Yaping, et al.
Publicado: (2022) -
Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor
por: McCann, Georgia A., et al.
Publicado: (2014) -
Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1
por: Su, Jung-Chen, et al.
Publicado: (2018) -
Granulin, a novel STAT3-interacting protein, enhances STAT3 transcriptional function and correlates with poorer prognosis in breast cancer
por: Yeh, Jennifer E., et al.
Publicado: (2015)